1M6MYTD1Y5YMAX
Loading quotes...
Forecast
| Buy |
4 |
| Hold |
0 |
| Sell |
0 |
News Go to news feed
There is currently no news available for this company. We are working on adding more providers to change this.
Financials
| (EUR) | September 2025 | |
|---|---|---|
| Revenue | 0 | - |
| Gross profit | -24.44K | - |
| Net profit | -28.74M | - |
| EBITDA | -24.6M | - |
Fundamentals
| Metric | Value |
|---|---|
Market capitalization | €355.36M |
Number of shares | 49.88M |
52-week high/low | €9.22 - €4.14 |
| Dividends | No |
Beta | 0.79 |
P/E ratio | -2.90 |
PEG ratio | -0.13 |
P/B ratio | 2.64 |
P/S ratio | 0.00 |
Company profile
| Name | Cybin |
| CEO | Eric So |
| Headquarters | Toronto,
on Canada |
| Website | |
| Sector | Health Care |
| Industry | Pharmaceuticals |
| Employees | 50 |
Discover assets
Shareholders of Cybin also invest in the following assets
